Skip to main content
. 2016 Nov 4;12(2):124–133. doi: 10.1016/j.ajps.2016.09.005

Table 2.

Percentage TMF dissolved from KPD or solid dispersions at 15 min (Q15) and 120 min (Q120), n = 3.

Formulation Drug dissolved (%) ± S.D.
Q15 Q120
KPD 15.21 ± 0.05 15.39 ± 0.14
KPD/HPMC (1:0.5) 24.58 ± 1.55 44.83 ± 1.09
KPD/HPMC (1:1) 34.27 ± 3.45 52.72 ± 4.45
KPD/HPMC (1:2) 43.71 ± 4.48 62.11 ± 2.17
KPD/HPMC (1:4) 21.20 ± 1.52 34.23 ± 1.23
KPD/PVA-co-PEG (1:0.5) 9.43 ± 0.10 12.07 ± 0.15
KPD/PVA-co-PEG (1:1) 75.74 ± 2.56 85.83 ± 1.10
KPD/PVA-co-PEG (1:2) 32.79 ± 1.46 37.08 ± 1.39
KPD/PVA-co-PEG (1:4) 8.83 ± 1.50 8.18 ± 0.08